- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03644225
Suction Based Characterization of Healthy and Diseased Skin
Mechanical Characterization of Healthy and Diseased Skin With Suction Based Assessment of Skin Deformability
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients with systemic sclerosis (SSc) show a thickening of the skin due to massive deposition of collagen and temporary edema in the dermis. The clinical palpation method is currently the only diagnosis method. For an objective detection a non-invasive skin elasticity measurement can be performed. The widely used approach is based on local tissue suction. This study aims at an identification and quantification of mechanical and structural properties of human skin. The results will then be compared in age- and gender matched control groups. For evaluation of the skin elasticity measurement the results will be compared to the clinical parametar validated, modified Rodnan skin score (mRSS).
The mechanical properties of healthy and diseased skin will be assessed by suction based measurements. The negative pressure is needed to gain a certain tissue elevation. Tissue elevation in response to a certain negative pressure as well as the time of retraction of tissue will be recorded and analyzed. (The different parameters depend on
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zürich, Switzerland, 8091
- Department of Rheumatology, University Hospital Zurich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
-Signed Informed Consent
Healthy volunteers:
- Age ≥18 years old
SSc-Patients:
- Age ≥18 years old
- Diagnosis of systemic sclerosis according to the ACR/EULAR 2013 criteria
- Skin thickening diagnosed by clinical expert
Exclusion Criteria:
- Known or suspected non-compliance, drug or alcohol abuse,
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Previous enrolment into the current study,
- Participants, who are unable to hold still
- Impaired skin at the regions of measurements
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Healthy Control
Healthy controls, who signed an informed consent, age ≥18 years old will be age and sex matched to the SSc patients
|
The mechanical properties of healthy and SSc-diseased skin will be assessed by suction based measurements with a new developed Aspirational Medical Device.
The mechanical properties of healthy and SSc-diseased skin will be assessed by CE-marked Cutometer MPA 580
|
|
Other: Systemic sclerosis patients
SSc patients who signed an Informed consent
|
The mechanical properties of healthy and SSc-diseased skin will be assessed by suction based measurements with a new developed Aspirational Medical Device.
The mechanical properties of healthy and SSc-diseased skin will be assessed by CE-marked Cutometer MPA 580
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mechanical characterization of healthy and diseased skin using novel aspiration device and comparing it to the already validated Cutometer® MPA 580.
Time Frame: one visit, one measurement, one year
|
The stiffness (mbar/mm) properties of healthy skin and SSc skin will be measured with the Aspiration Device and the Cutometer MPA 580.
For comparison of different locations on the body, back of the hand (left and right) and dorsal forearm (left and right) will be assessed for every participant at one time point (Visite 1).
|
one visit, one measurement, one year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Oliver Distler, Prof.Dr.med, Department of rheumatology
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Swissmedic:2017-MD_0045
- 2017-01154 (Other Identifier: Ethikkommission)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systemic Sclerosis
-
AmgenTerminatedDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicSpain, Japan, Romania, United States, Mexico, Argentina, Israel, Greece, Chile, Serbia, South Korea, Italy, Poland, Portugal, United Kingdom
-
Beijing GoBroad HospitalCARsgen Therapeutics Co., Ltd.RecruitingSystemic Lupus Erythematosus (SLE) | Systemic Sclerosis (SSc)China
-
AmgenTerminatedDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicSpain, Serbia
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Institute of Allergy and Infectious Diseases (NIAID)CompletedSystemic Scleroderma | Severe Systemic SclerosisUnited States
-
University of ManchesterCompletedEarly Diffuse Cutaneous Systemic Sclerosis
-
argenxRecruitingSystemic Sclerosis (SSc)Croatia, Spain, Denmark, Italy, Germany, Lithuania, United Kingdom, Netherlands, Poland, Belgium, United States, Switzerland, Mexico, Argentina, France, Bulgaria, Chile, Greece, Serbia, Portugal, Puerto Rico, Czechia, Romania, Hungary
-
University of PatrasRecruitingSSc-Systemic SclerosisGreece
-
Union Hospital, Tongji Medical College, Huazhong...CARsgen Therapeutics Co., Ltd.RecruitingSSc-Systemic SclerosisChina
-
The Children's Hospital of Zhejiang University...Guangzhou Women and Children's Medical CenterRecruitingSystemic Sclerosis (SSc)China, Christmas Island
Clinical Trials on Measurment with Aspirational Medical Device
-
Hospital Universitari Vall d'Hebron Research InstituteCompleted
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Istituto Italiano di TecnologiaEnrolling by invitation
-
VivaltisCEISO; Human PhysioCompleted
-
VivaltisCEISO; Human Physio; Pôle santé de la NartassièreCompletedUrinary Incontinence | Pelvic Floor DisordersFrance
-
Mastelli S.r.lCompleted
-
Karolinska University HospitalCompleted
-
IHF GmbH - Institut für HerzinfarktforschungRecruiting
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenCompletedQuality of Life | Breast Cancer | Self EfficacyBelgium